Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
EZALLOR SPRINKLE (ROSUVASTATIN CALCIUM) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
EZALLOR SPRINKLE
NDA
Get alerts
ROSUVASTATIN CALCIUM | N208647 | SUN PHARMACEUTICAL INDUSTRIES LTD
4 strengths
1 unique patent
0 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Price Trends
Medicare D
DMF
Approvals
Label
Products
Patent Timeline
1 unique patent by expiration date
All strengths
EQ 5MG BASE
EQ 10MG BASE
EQ 20MG BASE
EQ 40MG BASE
Active (1)
Today
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
Today
10413543
Feb. 12, 2036
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (4)
Sort:
Name
↑
Applicant
Strength
Approval
#001 — EQ 5MG BASE
RLD
1 patent
0 exclusivities
▴
CAPSULE;ORAL | Approved: Dec 18, 2018
Patents (1)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
10413543
Feb 12, 2036
—
—
Yes
—
—
#002 — EQ 10MG BASE
RLD
1 patent
0 exclusivities
▾
CAPSULE;ORAL | Approved: Dec 18, 2018
#003 — EQ 20MG BASE
RLD
1 patent
0 exclusivities
▾
CAPSULE;ORAL | Approved: Dec 18, 2018
#004 — EQ 40MG BASE
RLD
1 patent
0 exclusivities
▾
CAPSULE;ORAL | Approved: Dec 18, 2018